lupus Clinical Trials and Research
Also known as: systemic lupus erythematosus, sle, discoid lupus, cutaneous lupus, drug-induced lupus, lupus erythematosus · ICD-10: M32
Lupus is a chronic autoimmune disease where the body's immune system mistakenly attacks healthy tissues, causing widespread inflammation and damage. Clinical trial research aims to develop new therapies, improve diagnosis, and understand disease mechanisms. Find a Trial helps patients search for active studies.
Common questions about lupus clinical trials
Who can participate in lupus clinical trials?
Eligibility criteria vary by study, often including age, disease type, and specific health markers. Researchers carefully define these to ensure patient safety and study validity. Patients can review criteria on platforms like ClinicalTrials.gov.
What are the different phases of lupus clinical trials?
Clinical trials for lupus progress through phases 1 to 4. Early phases test safety and dosage, while later phases evaluate effectiveness and compare new treatments to existing ones. Data from ClinicalTrials.gov shows many studies in various stages.
Do lupus clinical trials cost money to participate in?
Generally, study-related medical care and investigational treatments in clinical trials are provided at no cost to participants. However, some routine medical care or travel expenses may not be covered. Details are outlined in the informed consent.
What are current research directions for lupus treatments?
Current research, as seen on NIH RePORTER and ClinicalTrials.gov, explores targeted therapies that modulate specific immune pathways, such as B-cell or T-cell inhibitors. Gene therapy and stem cell approaches are also being investigated to address disease activity and organ damage.
What types of interventions are commonly studied in lupus trials?
Lupus trials often investigate new immunosuppressants, biologics targeting specific immune cells or cytokines, and anti-inflammatory drugs. Researchers also study non-pharmacological interventions like lifestyle modifications or novel diagnostic tools, according to ClinicalTrials.gov.
Are there specific biomarkers important in lupus clinical trials?
Yes, biomarkers like anti-dsDNA antibodies, complement levels (C3, C4), and interferon signatures are often used to identify lupus patients, monitor disease activity, and assess treatment response. Research on new biomarkers is ongoing, as documented on NIH RePORTER.
What might prevent someone from joining a lupus clinical trial?
Common exclusion criteria for lupus trials include severe organ damage, active infections, certain co-existing medical conditions, or pregnancy. These criteria ensure patient safety and the study's scientific integrity, as detailed in study protocols on ClinicalTrials.gov.
Are there clinical trials for children with lupus?
Yes, pediatric lupus, or childhood-onset lupus, is a focus of some clinical trials. These studies are designed specifically for younger patients, investigating safe and effective treatments for their unique needs, as listed on ClinicalTrials.gov.
How to find a lupus trial that fits you
- Describe your lupus situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.